|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2008-11-26
|
|
pubmed:abstractText |
Angiotensin receptor blockers (ARBs) offer a new treatment alternative for patients with hypertension and heart failure. Due to comparatively high prices, most guidelines suggest ARBs be restricted to patients intolerant to angiotensin-converting enzyme inhibitors (ACEi). We analysed the prescribing patterns of ARBs in Sweden by combining prescription register data with patient self-reported data.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1432-1041
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1223-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18704389-Aged,
pubmed-meshheading:18704389-Angiotensin Receptor Antagonists,
pubmed-meshheading:18704389-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:18704389-Antihypertensive Agents,
pubmed-meshheading:18704389-Drug Utilization Review,
pubmed-meshheading:18704389-Female,
pubmed-meshheading:18704389-Humans,
pubmed-meshheading:18704389-Male,
pubmed-meshheading:18704389-Patient Compliance,
pubmed-meshheading:18704389-Prescription Drugs,
pubmed-meshheading:18704389-Questionnaires,
pubmed-meshheading:18704389-Registries,
pubmed-meshheading:18704389-Sweden
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines.
|
|
pubmed:affiliation |
National Corporation of Swedish Pharmacies (Apoteket AB), SE-118 81, Stockholm, Sweden. pia.frisk@apoteket.se
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
